Tobias Schwerd

4.0k total citations · 1 hit paper
44 papers, 1.8k citations indexed

About

Tobias Schwerd is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Tobias Schwerd has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 17 papers in Immunology and 16 papers in Epidemiology. Recurrent topics in Tobias Schwerd's work include Inflammatory Bowel Disease (23 papers), Microscopic Colitis (12 papers) and Eosinophilic Esophagitis (8 papers). Tobias Schwerd is often cited by papers focused on Inflammatory Bowel Disease (23 papers), Microscopic Colitis (12 papers) and Eosinophilic Esophagitis (8 papers). Tobias Schwerd collaborates with scholars based in Germany, Poland and United Kingdom. Tobias Schwerd's co-authors include Holm H. Uhlig, Sibylle Koletzko, Christoph Klein, Simon Travis, Scott B. Snapper, David C. Wilson, Dan Turner, Aleixo M. Muise, Abdul Elkadri and Jochen Kammermeier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Immunity and The Journal of Immunology.

In The Last Decade

Tobias Schwerd

38 papers receiving 1.8k citations

Hit Papers

The Diagnostic Approach to Monogenic Very Early Onset Inf... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tobias Schwerd Germany 14 1.1k 603 499 457 312 44 1.8k
Natalie J. Prescott United Kingdom 22 722 0.7× 951 1.6× 675 1.4× 329 0.7× 361 1.2× 45 1.9k
Sebastian Zundler Germany 23 1.0k 1.0× 760 1.3× 357 0.7× 394 0.9× 281 0.9× 85 1.9k
Kenichi Negoro Japan 20 659 0.6× 747 1.2× 306 0.6× 400 0.9× 362 1.2× 45 1.6k
Sanae Fujino Japan 9 1.4k 1.3× 708 1.2× 335 0.7× 345 0.8× 253 0.8× 10 2.1k
Liesbet Henckaerts Belgium 21 567 0.5× 1.1k 1.8× 382 0.8× 924 2.0× 432 1.4× 60 2.0k
Ulrich R. Foelsch Germany 11 642 0.6× 1.1k 1.8× 328 0.7× 605 1.3× 532 1.7× 22 1.7k
Ana Ízcue Germany 16 1.8k 1.7× 474 0.8× 425 0.9× 226 0.5× 214 0.7× 20 2.3k
Sofia Buonocore Belgium 13 2.5k 2.4× 801 1.3× 467 0.9× 312 0.7× 617 2.0× 21 3.1k
Chad Storer United States 12 414 0.4× 342 0.6× 516 1.0× 314 0.7× 164 0.5× 18 1.5k
Kazutaka Koganei Japan 19 1.4k 1.3× 1.0k 1.7× 424 0.8× 533 1.2× 623 2.0× 84 2.6k

Countries citing papers authored by Tobias Schwerd

Since Specialization
Citations

This map shows the geographic impact of Tobias Schwerd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Schwerd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Schwerd more than expected).

Fields of papers citing papers by Tobias Schwerd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Schwerd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Schwerd. The network helps show where Tobias Schwerd may publish in the future.

Co-authorship network of co-authors of Tobias Schwerd

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Schwerd. A scholar is included among the top collaborators of Tobias Schwerd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Schwerd. Tobias Schwerd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bischoff, Stephan C., Irina Blumenstein, Frank Jochum, et al.. (2025). S3-Leitlinie Klinische Ernährung bei chronisch-entzündlichen Darmerkrankungen. Aktuelle Ernährungsmedizin. 50(2). 80–114. 1 indexed citations
4.
Schwerd, Tobias, et al.. (2025). Therapeutic mechanisms of exclusive enteral nutrition in Crohn’s disease. Seminars in Immunopathology. 47(1). 28–28. 1 indexed citations
5.
Forné, Ignasi, Daniela Kugelmann, Tobias Straub, et al.. (2024). Persistent desmoglein-1 downregulation and periostin accumulation in histologic remission of eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 155(2). 505–519. 2 indexed citations
6.
Schwerd, Tobias, et al.. (2023). Children with Localized Crohn's Disease Benefit from Early Ileocecal Resection and Perioperative Anti-Tumor Necrosis Factor Therapy. European Journal of Pediatric Surgery. 34(3). 236–244. 5 indexed citations
7.
Schwerd, Tobias, et al.. (2022). 3.21 Enteral Nutrition in Inflammatory Bowel Disease. World review of nutrition and dietetics. 124. 368–373.
8.
Li, Yue, Thomas Fröhlich, Thomas Magg, et al.. (2022). Valosin-containing protein-regulated endoplasmic reticulum stress causes NOD2-dependent inflammatory responses. Scientific Reports. 12(1). 3906–3906. 2 indexed citations
9.
Rubio‐Acero, Raquel, Renée Stark, Marie Standl, et al.. (2021). Following Pediatric and Adult IBD Patients through the COVID-19 Pandemic: Changes in Psychosocial Burden and Perception of Infection Risk and Harm over Time. Journal of Clinical Medicine. 10(18). 4124–4124. 10 indexed citations
10.
Schwerd, Tobias, et al.. (2021). Esophageal Perforation and EVAC in Pediatric Patients: A Case Series of Four Children. Frontiers in Pediatrics. 9. 727472–727472. 4 indexed citations
11.
Lanz, Anna-Lisa, Tobias Schwerd, Eberhard Lurz, et al.. (2021). Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency. Clinical Immunology. 229. 108779–108779. 19 indexed citations
12.
Schwerd, Tobias, Stephen R.F. Twigg, Dominik Aschenbrenner, et al.. (2020). A variant in IL6ST with a selective IL-11 signaling defect in human and mouse. Bone Research. 8(1). 24–24. 21 indexed citations
14.
Uhlig, Holm H., Fabienne Charbit‐Henrion, Daniel Kotlarz, et al.. (2020). Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 72(3). 456–473. 79 indexed citations
15.
Shahin, Tala, Dominik Aschenbrenner, Deniz Çağdaş, et al.. (2018). Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function. Haematologica. 104(3). 609–621. 61 indexed citations
16.
Schwerd, Tobias, Manfred Schürmann, Hannah Chen, et al.. (2015). A recessive form of extreme macrocephaly and mild intellectual disability complements the spectrum of PTEN hamartoma tumour syndrome. European Journal of Human Genetics. 24(6). 889–894. 6 indexed citations
17.
Canning, Peter, Tobias Schwerd, Matouš Hrdinka, et al.. (2015). Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors. Chemistry & Biology. 22(9). 1174–1184. 77 indexed citations
18.
Uhlig, Holm H., Tobias Schwerd, Sibylle Koletzko, et al.. (2014). The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease. Gastroenterology. 147(5). 990–1007.e3. 437 indexed citations breakdown →
19.
Schmidt, Andreas, Tobias Schwerd, Johannes C. Hellmuth, et al.. (2009). 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proceedings of the National Academy of Sciences. 106(29). 12067–12072. 325 indexed citations
20.
Anz, David, Viktor H. Koelzer, Raffael Thaler, et al.. (2009). Immunostimulatory RNA Blocks Suppression by Regulatory T Cells. The Journal of Immunology. 184(2). 939–946. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026